TheChek News Flow

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings: PLAY +9.3%, KFY +0.9%, TIVO +0.2%

Companies trading higher in after hours in reaction to news: AKBA +65.2% (announced positive top-line results from its Phase 2 study of vadadustat in dialysis patients with anemia related to chronic kidney disease), VTAE +29.6% (announced positive top-line results from initial phase 1 study of first-in-class RORyt Inhibitor VTP-43742 in autoimmune disorders), CLR +1.6% (announced plans to reduce its 2015 capital budget by $300-350 million more than previously approved)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings: PSUN -16.7%, FCEL -9.2%, MW -6.1%, PBY -3.9%, CLLS -0.9%

Companies trading lower in after hours in reaction to news: TTPH -77.8% (announced eravacycline did not achieve primary endpoint in pivotal portion of complicated urinary tract infections Trial), ZQK -60.4% (Bloomberg reporting co will prepare a bankruptcy filing), FLXN -41.4% (reported top-line data from pivotal phase 2b clinical trial for FX006 in patients with moderate to severe osteoarthritis (OA) knee pain; primary endpoint of study not met), AQXP -5.9% (announced proposed public offering of $75 million of common stock), CMRX -5.2% (provided clinical development update for Brincidofovir, stating that SUPPRESS data continues to be expected in early 2016), FPRX -3.4% (initiated patient dosing in its Phase 1a/1b clinical trial, evaluating the immunotherapy combination of FPA008 with Opdivo), UAL -1.7% (named Oscar Munoz as President and CEO; announced that its executive vice president of communications and government affairs and its senior vice president of corporate and government affairs have stepped down), DY -1.7% (announced a private placement offering of $400 mln in convertible senior notes due 2021; authorizes the repurchase of up to $75 million of its common stock)